top of page

Titre de la page

Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs.

for the Scientific Communities

At AcedrA, we provide the scientific communities in the MENA region with access to cutting-edge technologies such as CRISPR/Cas9, CAR-T cell therapy, stem cell technology, enzyme replacement therapies, antibody-drug conjugates, and more. Our team of experienced professionals is dedicated to helping scientific and medical communities to access innovative treatments and therapies that improve the lives of people in the MENA region. We are committed to delivering quality products and services that enable researchers and medical professionals to unlock their potential for success. By leveraging our expertise in innovative technologies, we can empower scientists and healthcare professionals with the tools they need to drive progress in medical research. We believe that with our help, the MENA region can become a hub for scientific breakthroughs and advancements.


We strive to bring the latest, safest and most advanced technologies to the region and ensure that our clients have access to the resources they need. At AcedrA, we are proud of our commitment to serve both the scientific community and local communities in the MENA region. We believe that through collaboration with healthcare professionals, researchers, clinicians, governments and organisations, we can create a positive future for everyone. With our help, the region has the potential to become an innovation powerhouse for medical research and development.


We invite you to join us on our mission to drive progress in medical research and support the scientific communities in MENA. Through our dedication to providing innovative technologies,


"Clustered Regularly Interspaced Short Palindromic Repeats - CRISPR Associated Protein 9" 


It is a gene editing technology that has revolutionized the field of biotechnology. It uses a bacterial enzyme, CAS9, which can be programmed to recognize and cut specific sequences of DNA. This allows for the precise editing of genes without damaging surrounding cells. It can be used to treat a variety of diseases including cancer, HIV, and inherited genetic disorders.

Stem Cells

Stem cells are an important tool in medical research and therapy. They are able to differentiate into specialized cell types, offering potential treatments for a variety of diseases. Stem cell therapy has been used in the treatment of cancer, Parkinson's disease, spinal cord injuries, and other conditions. The cells can be harvested from adult tissue or derived from induced pluripotent stem cells, which are reprogrammed adult cells. In addition to their use in treating human disease, stem cells have been used to create disease models and study pathogenesis


"Chimeric Antigen Receptor - T Cell Receptor" 


It is a form of immunotherapy that involves the modification of a patient’s own T cells to recognize and fight existing cancer or other diseases. In this form of treatment, a patient's T cells are collected from their blood and modified in the laboratory with special receptors known as chimeric antigen receptors (CARs). The modified T cells, now known as CAR-T cells, are then reinfused into the patient's body.

Protein Targeted

Protein-targeted therapeutics is a type of molecular medicine that focuses on targeting specific proteins in the body to treat diseases. By selectively blocking, modulating, or activating certain proteins, these therapies can affect biological pathways and lead to therapeutic benefits. This is useful for treating chronic conditions such as cancer, autoimmune diseases, and neurological disorders. Examples include monoclonal antibodies, protein-based small molecules, aptamers, and engineered proteins known as fusion proteins.

RNA Targeted

RNA-targeted therapeutics provide a promising approach that can help address the limitations of existing treatments. Currently, there are two main types of RNA-targeted therapies being developed: small interfering RNAs (siRNAs) and messenger RNA activators (mRNAs). siRNAs are short pieces of double-stranded RNA that selectively silence genes, while mRNAs directly upregulate gene expression. Both approaches have the potential to revolutionize the treatment of a variety of diseases, including genetic disorders and cancer.


Biosimilars or Biobetters are biological therapies that are developed to be highly similar, though not identical, to an already referenced drug. As they are produced by a different manufacturer than the originator of the reference drug, they must undergo comprehensive analytical and clinical studies in order to prove safety, quality, and efficacy with comparable characteristics to their reference drug. Following regulatory approval, biosimilars can be used to treat a wide range of diseases, enabling wider access to treatments for patients at lower costs.

Academia, Researchers

At AcedrA we understand that the challenge of advancing medical treatments is a complex one. We are committed to helping researchers and academia to find new opportunities through which they can leverage innovative therapies to bridge this gap

for Healthcare Professionals

AcedrA is an innovative platform designed to bridge the gap between healthcare professionals and unmet medical needs. Our platform enables healthcare providers to quickly analyze patient data to identify potential treatments or therapies that can address a patient's specific medical condition. This powerful tool allows healthcare professionals to make informed decisions about treatment strategies, helping them provide better care for their patients. AcedrA also provides insights into unmet medical needs, allowing healthcare professionals to identify areas of potential intervention and make more impactful decisions. By leveraging the power of data and analytics, AcedrA is empowering healthcare providers to deliver personalized patient care that meets their individual needs. With our platform, healthcare providers can provide quality care with confidence and provide optimal outcomes for their patients.

Named Patient Programs
Compassionate Use
Patient Safety
Pre-Approved Medicines
Product Inquiry
Conitnuous Learning
Comparator Sourcing
Medical Training
Clinical Supply
Unlicensed Medicines

Transparency & Disclosure We recognize that patients expect transparency around these relationships to feel confident that HCPs are impartial and always recommend the most appropriate treatment options. The payments and transfers of value disclosed here were made for activities such as providing professional advice about how medicines are used in practice, sharing professional expertise at medical education meetings, and taking part in advisory boards, research, and educational grants:

Healthcare Professionals

AcedrA is also dedicated to providing access to the latest medical research and treatments. Our extensive database of resources allows healthcare professionals to stay up-to-date with the most recent advancements in medical treatments and therapies, helping them make informed decisions about patient care. Additionally, our platform offers data-driven insights that allow healthcare providers to identify trends and patterns in patient care, allowing them to make more informed decisions about treatment strategies

for Individual Patients

AcedrA is an innovative medical technology company helping individual patients with unmet medical needs. Our proprietary technologies and processes allow us to develop and implement personalized treatments for conditions that have no approved therapies. We are dedicated to improving the lives of patients with serious diseases, giving them a solution when other traditional methods have failed.


Our team of medical professionals and researchers is committed to finding solutions to complex clinical problems with our cutting-edge technologies. We are continually developing new treatments and approaches that can help patients who have exhausted all other possibilities. Our dedication to patient care means we strive to provide the best possible outcomes, while also addressing any concerns or questions they may have.

Patient Safety
Product Inquiry

Individual Patients

If you are an individual patient or visiting this site on behalf of a patient who suffers from an unmet medical need, please contact your healthcare provider (e.g. doctor, pharmacist, or hospital). AcedrA, once contacted by your healthcare provider, will discuss the options for gaining access to the requested therapy.

for Patient Advocacy Groups

Our team is dedicated to providing high-quality patient support and services. We are continuously working to improve our existing products and develop new solutions that meet the needs of our partners’ patients. By doing so, we remain committed to bettering the lives of those who need it most. We believe that no patient should be left behind—everyone deserves access to the best care available. We look forward to working with our partners and patient advocacy groups to advance healthcare solutions and make a positive impact on patients regionally. We strive to provide our partners and customers with high-quality medical solutions that best meet the unique needs of their patients. To achieve this, we regularly evaluate patient feedback collected from patient advocacy groups and other relevant sources to ensure our products and services always meet their needs. We also use the insights gathered to inform our research and development initiatives, ensuring that all new products are designed with patient needs in mind. By doing so, we can continuously improve our offerings and provide optimal solutions to best suit our partners’ patient base. Our goal is to ensure that all patients have access to the best possible medical care and treatments.

Patient Safety
Product Inquiry
Compassionate Use

Patient Advocacy Groups

We are proud to be working with a patient advocacy group whose mission is to empower people living with unmet medical needs. Through this partnership, AcedrA has been able to provide patients access to the most advanced technology and resources available.  Our collaboration with the patient advocacy group means that we are able to offer a range of innovative solutions for those living with unmet medical needs, giving them more control over their health outcomes and quality of life. We are excited to see the positive impact this partnership will have on all those involved.

Together, we can make a difference in the lives of those living with unmet medical needs!

for Corporates Biotech, Pharma, MedTech

AcedrA's MSLs offer comprehensive medical affairs services to pharmaceutical, biotechnology, and medical technology companies. Our MSL team is composed of experienced medical advisors and MSLs, who have a deep understanding of all areas of the industry and provide insights into the ever-changing regulatory landscape. MSLs are experts in their field, providing a comprehensive range of medical affairs services, including scientific exchange and market access. Our MSLs create and implement tailored strategies that fit the needs of each company, helping them to maximize revenues while maintaining compliance with industry regulations. By utilizing our MSLs’ expertise, clients can improve their product positioning in the marketplace and gain visibility amongst key stakeholders. MSLs also provide support in areas such as product launches, medical education, promotional campaigns, and publications. AcedrA's MSLs are dedicated to providing our customers with the highest level of medical affairs services possible.

Product Inquiry
Compassionate Use
Named Patient Programs
Pre-Approved Medicines
Comparator Sourcing
Clinical Supply
Unlicensed Medicines

Medical Tech

By leveraging the expertise and experience of our MSL team, pharmaceutical, biotechnology, and medical technology companies can be confident in the quality of their medical affairs services. We are dedicated to providing our customers with the best possible solutions for their needs. With AcedrA, you can trust that your MSL team will provide reliable, comprehensive medical affairs services tailored to meet each and every one of your business’s requirements. 

Let us show you the difference AcedrA MSLs can make


Patient Safety

Or call AcedrA Pharmacovigilance Hotline KSA: 8001240411 (Toll-Free) | International: +966 11 400 0036

AcedrA's pharmacovigilance system is designed to help protect patient safety. Our team of qualified professionals quickly identifies any potential risks and takes the necessary steps to prevent harm to patients. We have established robust processes for data collection, analysis, and reporting in order to ensure accurate risk assessments and informed decisions. Additionally, our dedicated teams continually review and monitor our pharmacovigilance system to ensure its effectiveness. With AcedrA's comprehensive pharmacovigilance system, you can rest assured that your patients are always in safe hands.

bottom of page